Diabetes Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Diabetes stocks.

Diabetes Stocks Recent News

Date Stock Title
May 17 ABT Abbott (ABT) Down 0.4% Since Last Earnings Report: Can It Rebound?
May 17 ALKS The Bottom Fishing Club: Alkermes Has Great Value And Safety
May 16 BDX Becton, Dickinson and Company: Stagnating All Along
May 16 ABT These Dividend Stocks Are an Investor's Best Friend
May 15 ABT Tudor Investment's top buys and sells in Q1
May 15 ASND FDA Pushes Review Date For Ascendis Pharma's Hormone Disorder Candidate By Three Months
May 15 ABT Abbott recalls HeartMate 3 over potential blood leakage, air issues
May 15 ASND FDA Delays Decision on Ascendis' (ASND) Hormone Therapy Filing
May 15 ABT Abbott recalls Heartmate pump after 70 injuries, 2 deaths reported
May 15 BDX Women in U.S. Can Now Collect Their Own Sample for Cervical Cancer Screening
May 15 ALIM Alimera Sciences Inc (ALIM) Q1 2024 Earnings Call Transcript Highlights: Soaring Revenues and ...
May 15 BLTE Belite Bio, Inc 2024 Q1 - Results - Earnings Call Presentation
May 15 BLTE Belite Bio, Inc (BLTE) Q1 2024 Earnings Call Transcript
May 14 BLTE Belite Bio reports Q1 results
May 14 ASND US Equity Markets Close Higher Tuesday as Producer Prices Rise
May 14 ASND Ascendis Pharma says FDA has delayed TransCon PTH review
May 14 ASND UPDATE 1-FDA extends review of Ascendis Pharma's hormone disorder therapy
May 14 ASND Ascendis Pharma Announces Extension of U.S. Food and Drug Administration Review Period for TransCon™ PTH for Adults with Hypoparathyroidism
May 14 ALIM Alimera Sciences, Inc. (ALIM) Q1 2024 Earnings Call Transcript
May 14 ALIM Alimera Sciences (ALIM) Reports Q1 Loss, Misses Revenue Estimates
Diabetes

Diabetes mellitus (DM), commonly referred to as diabetes, is a group of metabolic disorders in which there are high blood sugar levels over a prolonged period. Symptoms of high blood sugar include frequent urination, increased thirst, and increased hunger. If left untreated, diabetes can cause many complications. Acute complications can include diabetic ketoacidosis, hyperosmolar hyperglycemic state, or death. Serious long-term complications include cardiovascular disease, stroke, chronic kidney disease, foot ulcers, and damage to the eyes.Diabetes is due to either the pancreas not producing enough insulin, or the cells of the body not responding properly to the insulin produced. There are three main types of diabetes mellitus:
Type 1 DM results from the pancreas' failure to produce enough insulin due to loss of beta cells. This form was previously referred to as "insulin-dependent diabetes mellitus" (IDDM) or "juvenile diabetes". The cause is unknown.
Type 2 DM begins with insulin resistance, a condition in which cells fail to respond to insulin properly. As the disease progresses, a lack of insulin may also develop. This form was previously referred to as "non insulin-dependent diabetes mellitus" (NIDDM) or "adult-onset diabetes". The most common cause is a combination of excessive body weight and insufficient exercise.
Gestational diabetes is the third main form, and occurs when pregnant women without a previous history of diabetes develop high blood sugar levels.Prevention and treatment involve maintaining a healthy diet, regular physical exercise, a normal body weight, and avoiding use of tobacco. Control of blood pressure and maintaining proper foot care are important for people with the disease. Type 1 DM must be managed with insulin injections. Type 2 DM may be treated with medications with or without insulin. Insulin and some oral medications can cause low blood sugar. Weight loss surgery in those with obesity is sometimes an effective measure in those with type 2 DM. Gestational diabetes usually resolves after the birth of the baby.As of 2015, an estimated 415 million people had diabetes worldwide, with type 2 DM making up about 90% of the cases. This represents 8.3% of the adult population, with equal rates in both women and men. As of 2014, trends suggested the rate would continue to rise. Diabetes at least doubles a person's risk of early death. From 2012 to 2015, approximately 1.5 to 5.0 million deaths each year resulted from diabetes. The global economic cost of diabetes in 2014 was estimated to be US$612 billion. In the United States, diabetes cost $245 billion in 2012.

Browse All Tags